APOTHEEK TAKOFARMA
Board
1 director, no change since 2024Director
in office according to the deed of 12-01-2024
listed in the 2025 annual accounts, filed on 27-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 12. Bevoegdheden van het bestuursorgaan Als er slechts één bestuurder is, is het geheel van de bevoegdheden van de bestuurders aan…”deed of 12-01-2024
Mandates through the years
2 names, the dashed line is todayK. KOLACNY
Director
Director
TAMBEUR Lea
Manager
Manager
BoardEarliermandate already running before its first mention
Mandates as a list
- K. KOLACNY
- Director, since before 31-12-2021
- TAMBEUR Lea
- Manager, from before 31-12-2021 to 12-01-2024
Control
Parent
Equity €869,379
Profit €65,768 in 2026 (profit €38,832 in 2025)
Checked score 93
Source: accounts K. KOLACNY 31-03-2026
100%
This company
APOTHEEK TAKOFARMA
Equity €695,297
Profit €77,312 in 2025
Capital
- Contribution
- €20,000
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
Source: lists of holdings in the owners' accounts
Articles of association
deed of 12-01-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director“Bestuursorgaan, algemene vergadering bepaalt aantal,duur opdracht en bij meerdere bevoegdheid”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of May at 20:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle machten artikel 2:87 WVV zonder bijzondere machtiging, bestuurder(s) in functie”